The iStent Receives FDA Approval
The iStent Trabecular Micro-Bypass (Glaukos
Corporation) has received approval from the FDA, a
decision that has the potential to change the way glaucoma
is treated in the United States. The iStent, which
is the first ab interno glaucoma implant to be approved
in this country, is indicated for use in conjunction with
...